Optimizing cardiac status in the preliver transplant candidate

Area of Science:

• Cardiology
• Hepatology
• Transplant Surgery

Background:

• Liver transplantation is a standard treatment for end-stage liver disease.
• Transplant candidates are aging and present with increased cardiac comorbidities.
• Cardiovascular disease is a primary cause of post-transplant morbidity and mortality.

Approach:

• Review outlines cardiovascular risk stratification for liver transplant candidates.
• Incorporates American Heart Association/American College of Cardiology (AHA/ACC) guidelines.
• Considers recent expert consensus documents on cardiac evaluation.

Key Points:

• Preoperative cardiac risk stratification and management are crucial.
• The optimal frequency for cardiac surveillance post-transplant is undefined.
• The ideal timing for cardiac interventions in end-stage liver disease patients remains uncertain.

Conclusions:

• A structured approach to cardiovascular risk assessment is presented.
• Further research is necessary to determine optimal timing and methods for cardiac interventions.